Biotech investing requires portfolio-level probabilistic risk sizing
The guest presented a framework for biotech venture investing where portfolio construction of roughly 20 diversified bets is used to systematically offset high individual project failure rates.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day — no card required.